Google DeepMind Releases AlphaGenome 2 for Cell-Type-Specific Variant Effects

researchMarkTechPostNov 11, 2026

Google DeepMind released AlphaGenome 2, a conditional DNA sequence model that predicts regulatory activity and variant effects per cell type. It is available via the AlphaGenome API for non-commercial research. The post Google DeepMind Releases AlphaGenome...

Impact: LowConfidence: LowNovelty: Incremental
researchmarktechpost

See the whole story

Read the original on MarkTechPost

Sens.ai aggregates and assesses published reporting. The assessment above is machine generated; the original source is authoritative.